A new approach for elimination of gastric cancer deaths in Japan.
about
Gastric cancer: descriptive epidemiology, risk factors, screening, and preventionRoadmap for elimination of gastric cancer in KoreaHelicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysisDiagnosis and management of high risk group for gastric cancerTreatment of Helicobacter pylori infection: Where are we now?Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected PatientsManaging the changing burden of cancer in Asia.Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric CancerStrategies for eliminating death from gastric cancer in JapanEndoscopic gastric cancer screening and surveillance in high-risk groups.Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancerAppropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese?Blood Groups in Infection and Host Susceptibility.Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Helicobacter Pylori and Gastric Cancer: Clinical Aspects.Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer.Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind studyRoadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.Characteristics of gastric cancer in AsiaReview article: the epidemiology and prevention of gastric cancer.Implementation of gastric cancer screening - the global experience.Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.Changing Trends in Stomach Cancer Throughout the World.Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).RE: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Response.RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
P2860
Q26849435-466F7F1D-D872-4204-A33D-9865525A7919Q27013986-CE8ECDE7-BD17-457F-854E-79DF8BE43611Q27333657-657D3592-EDDD-4F7B-A5B7-3F72C97A0E9DQ27496690-B3FD6F98-CC3E-435C-A88D-0FA947458C43Q28084323-3894E8C6-7C30-4865-9B96-56471126302AQ30251567-D8BC3277-6ED1-4E0B-AF66-C3E253C1B938Q33436669-5942BD85-5510-4C5E-99F6-A3A15005F5CEQ33643009-42B8E924-AFCF-4927-A147-B4AF05236EEFQ33893567-2D015662-6BDD-43ED-B4A3-4EEC5623AD05Q33911623-C82798CF-2EE7-4FE0-A855-78AA0A4BF401Q34305338-8B033308-29E5-4F49-A119-2B970D88F69FQ34544931-BA7A2A40-4D49-4081-A1F9-7BB8B992F41AQ34658657-8FD5F970-DFC7-43BD-82C0-E4473F50D646Q35261353-785FCA8C-2AEE-4C58-960F-7ED962DC22AAQ35598058-4894BB14-FB45-4B50-9962-D6D69DC117A2Q35699847-D1F56D83-828C-41FA-B9D6-EE81DE37861BQ35763408-F6F42E8A-CA95-4E8A-B42D-E2248E0AA312Q36181286-835AF759-0B5C-40BE-8A62-44E9CEAFB61CQ36209645-CD406D7A-4B6B-40C7-8D74-FF540249996BQ36695975-00556638-DBE3-4993-B6B1-144383B09B2EQ37138735-2CF1E2A0-D4B5-407E-A97C-CF93F300F65CQ37282589-48A95166-BACF-410A-9A6D-4F5ED0D97452Q37491386-9C00D09C-2196-4F61-B6F7-28473BF16A15Q37533456-5C39F669-E3F4-4D82-9413-0FEBD69AC09EQ37587260-FAB930EF-8597-4DC4-9160-03C351E2F250Q37724638-4443D91A-AE0E-4E09-8D56-430AEC53B83CQ38218870-AFF1AD6D-D80A-4CFB-BD36-3E47C8FDF95AQ38273499-E6FE4A86-18FF-46E6-A954-BC556C17F31FQ38644084-1A77B749-D764-4554-8E92-F5E16531DE08Q39449701-2DA3D64E-1DE6-437B-8202-4C29F8AB38CCQ40189054-3B1FB41D-9EA5-4D27-91FE-C723B8143BA4Q40314735-EEAF1A64-D600-4F79-AA4E-A207AD3FA6DBQ41231085-DBB0AB41-83EE-4135-B1F3-3B0F65CBE11CQ41236727-E75310A7-1BBF-40C2-9163-2A6EC9BBCB7CQ41592572-1397E837-3EB2-4771-8C27-619B9C2EB873Q42991225-C2DCA799-644D-4207-AF0F-BCDE07460435Q43155529-9CA32393-CFB1-4991-AE8B-2774D2F3762C
P2860
A new approach for elimination of gastric cancer deaths in Japan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A new approach for elimination of gastric cancer deaths in Japan.
@ast
A new approach for elimination of gastric cancer deaths in Japan.
@en
type
label
A new approach for elimination of gastric cancer deaths in Japan.
@ast
A new approach for elimination of gastric cancer deaths in Japan.
@en
prefLabel
A new approach for elimination of gastric cancer deaths in Japan.
@ast
A new approach for elimination of gastric cancer deaths in Japan.
@en
P2860
P356
P1476
A new approach for elimination of gastric cancer deaths in Japan.
@en
P2093
Masahiro Asaka
P2860
P304
P356
10.1002/IJC.27965
P577
2012-12-21T00:00:00Z